TECLISTAMAB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): MAJESTEC-1 SUBGROUP ANALYSIS BY LINES OF THERAPIES
NWCJV Donka, R Popatb, L Rosiolc, B Besemerd, JM Lopeze, D Trancuccif, R Veronag, T Stephensong, K Chastainf, N Bahlish
a Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
b University College London Hospitals, NHS Foundation Trust, London, United Kingdom
c Hospital Clínic de Barcelona (IDIBAPS), Barcelona, Spain
d University of Tuebingen, Tuebingen, Germany
e Hematología Hospital 12 de Octubre, Madrid, Spain
f Janssen Research & Development, Raritan, United States
g Janssen Research & Development, Spring House, United States
h Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
Read
1700
Timeswas read the article
511
Total PDF
1189
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 57 | 9 | 66 |
| 2025 April | 55 | 17 | 72 |
| 2025 March | 66 | 13 | 79 |
| 2025 February | 64 | 29 | 93 |
| 2025 January | 57 | 30 | 87 |
| 2024 December | 54 | 18 | 72 |
| 2024 November | 73 | 26 | 99 |
| 2024 October | 81 | 47 | 128 |
| 2024 September | 91 | 30 | 121 |
| 2024 August | 61 | 36 | 97 |
| 2024 July | 58 | 30 | 88 |
| 2024 June | 68 | 41 | 109 |
| 2024 May | 62 | 32 | 94 |
| 2024 April | 78 | 35 | 113 |
| 2024 March | 28 | 16 | 44 |
| 2024 February | 61 | 18 | 79 |
| 2024 January | 60 | 16 | 76 |
| 2023 December | 49 | 23 | 72 |
| 2023 November | 58 | 37 | 95 |
| 2023 October | 8 | 8 | 16 |
Show all
